(CRSP) Crispr Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Crispr Therapeutics | (CRSP) share price targets
Complete technical analysis of Crispr Therapeutics (CRSP) by charts plus indicators, forecast predictions and share price targets for Crispr Therapeutics (CRSP)
Crispr Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-06-24 View latest technical analysis
10 day averaged volume of Crispr Therapeutics is 1692390
| Date | Daily Closing Price | Open | High | Low | Volume |
| 24 Mon Jun 2024 | 57.94 | 56.27 | 58.31 | 56.11 | 0.648 times |
| 21 Fri Jun 2024 | 56.24 | 59.34 | 60.46 | 55.08 | 2.375 times |
| 20 Thu Jun 2024 | 59.60 | 60.05 | 60.19 | 58.05 | 0.746 times |
| 18 Tue Jun 2024 | 60.57 | 62.03 | 62.17 | 60.41 | 0.534 times |
| 18 Tue Jun 2024 | 60.57 | 62.03 | 62.17 | 60.41 | 0.534 times |
| 17 Mon Jun 2024 | 61.79 | 62.85 | 62.89 | 61.14 | 0.731 times |
| 14 Fri Jun 2024 | 63.56 | 64.78 | 65.39 | 63.49 | 0.637 times |
| 13 Thu Jun 2024 | 65.26 | 66.00 | 67.88 | 64.90 | 1.046 times |
| 12 Wed Jun 2024 | 64.83 | 64.20 | 67.87 | 63.61 | 1.585 times |
| 11 Tue Jun 2024 | 62.31 | 59.57 | 63.42 | 58.28 | 1.161 times |
My analysis of stock is bearish for shortterm, and stock might move down till 55.7 or till 51.6. Use a stoploss of 59.11 and if the stock hits stoploss, then it can shoot up till 62.5
Share price targets for Crispr Therapeutics (CRSP)
| Target Type | Value |
| Downside Target | 51.02 |
| Downside Target | 52.73 |
| Downside Target | 54.52 |
| Upside Target | 58.31 |
| Upside Target | 62.08 |
| Upside Target | 62.89 |
| Upside Target | 67.52 |
| Upside Target | 67.88 |
| Upside Target | 68.39 |
| Upside Target | 87.08 |
| Upside Target | 91.10 |
Intraday share price targets for Crispr Therapeutics (CRSP)
| Target Type | Value |
| Downside Intraday Target | 56.6 |
| Downside Intraday Target | 55.25 |
| Upside Intraday Target | 58.8 |
| Upside Intraday Target | 59.65 |
| Downside Intraday Target | 57.45 |
Weekly technical analysis of Crispr Therapeutics (CRSP)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 24 Mon Jun 2024 | 57.94 | 56.27 | 58.31 | 56.11 | 0.177 times |
| 21 Fri Jun 2024 | 56.24 | 62.03 | 62.17 | 55.08 | 2.891 times |
| 18 Tue Jun 2024 | 60.57 | 62.85 | 62.89 | 60.41 | 0.249 times |
| 14 Fri Jun 2024 | 63.56 | 57.00 | 67.88 | 56.80 | 1.432 times |
| 07 Fri Jun 2024 | 57.87 | 54.82 | 60.26 | 54.52 | 1.558 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Crispr Therapeutics (CRSP)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 24 Mon Jun 2024 | 57.94 | 54.82 | 67.88 | 54.52 | 0.862 times |
| 31 Fri May 2024 | 53.74 | 53.16 | 59.18 | 51.02 | 0.974 times |
| 30 Tue Apr 2024 | 52.99 | 68.14 | 68.39 | 52.73 | 1.058 times |
| 28 Thu Mar 2024 | 68.16 | 84.36 | 87.08 | 67.52 | 0.53 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Crispr Therapeutics (CRSP)
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Crispr Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Crispr Therapeutics in short term but the sell signal is initial and weak.
Crispr Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Crispr Therapeutics in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Crispr Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 60.95 and Crispr Therapeutics (CRSP) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Crispr Therapeutics (CRSP) stock. Volume based technical analysis of Crispr Therapeutics (CRSP) stock is negative.
Crispr Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Crispr Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Crispr Therapeutics in short term but the sell signal is initial and weak.
Crispr Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Crispr Therapeutics in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Crispr Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 60.95 and Crispr Therapeutics (CRSP) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Crispr Therapeutics (CRSP) stock. Volume based technical analysis of Crispr Therapeutics (CRSP) stock is negative.
Crispr Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.